But yet NWBO's SEC 10K filings are the basis for every point. Do you not believe what NWBO has repeatedly stated in their 10K filings filed under penalty of perjury??
NWBO has reported both PFS and OS measures were confounded and that regulators may not accept all of the trial protocol changes. Ramble on all you want, but again NWBO has been making the statements you are contesting.
Share price reaction to the TLD is also factual. They released the TLD data and the share price DIDN'T go up!!! Go figure -- in a biotech world that is certainly NOT a positive sign that investors are buying the TLD results. Are you contesting that, really?
Market Data 
Markets 
AI
